Skip to main content
Clinical Trials/NCT06216678
NCT06216678RecruitingNot Applicable

The Effects of Healthy Diets With Plant Oils on Heart and Metabolic Health: A Randomized, Crossover, Controlled-feeding Study

Penn State University1 site in 1 country52 target enrollmentStarted: September 9, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
52
Locations
1
Primary Endpoint
LDL-cholesterol concentration

Study Overview

Brief Summary

This study will examine the effect of a healthy diet containing cottonseed oil compared to healthy diets containing other commonly consumed plant oils on biomarkers of heart and metabolic health after 4 weeks.

Detailed Description

This is a 3-period randomized crossover complete feeding study examining if a dietary pattern containing cottonseed oil improves lipids/lipoproteins and other cardiometabolic disease risk factors to a greater extent than a fatty acid matched diet devoid of cottonseed oil and a diet lower in polyunsaturated fatty acids (PUFA) and saturated fatty acids (SFA), but with a matched PUFA:SFA ratio

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • LDL-C ≥100 mg/dL and ≤190 mg/dL
  • BMI of 25-40 kg/m2
  • Blood pressure <140/90 mmHg
  • Fasting blood glucose <126 mg/dL
  • Fasting triglycerides <350 mg/dL
  • ≤10% change in body weight for 6 months prior to enrollment

Exclusion Criteria

  • Type 1 or type 2 diabetes or fasting blood glucose ≥126 mg/dL
  • Prescription of anti-hypertensive, lipid lowering or glucose lowering drugs
  • Intake of supplements that affect the outcomes of interest and unwilling to cease during the study period
  • Diagnosed liver, kidney, or autoimmune disease
  • Prior cardiovascular event (e.g., stroke, heart attack)
  • Current pregnancy or intention of pregnancy within the next 6 months
  • Lactation within prior 6 months
  • Follows a vegetarian or vegan diet
  • Food allergies/intolerance/sensitives/dislikes of foods included in the study menu
  • Antibiotic use within the prior 1 month
  • Oral steroid use within the prior 1 month
  • Use of tobacco or nicotine containing products with in the past 6 months
  • Cancer any site within the past 10 years (eligible if ≥10 years without recurrence) or non-melanoma skin cancer with in the past 5 years (eligible if ≥5 years without recurrence)
  • Participation in another clinical trial within 30 days of baseline
  • Currently following a restricted or weight loss diet
  • Prior bariatric surgery
  • Intake of >14 alcoholic drinks/week and/or lack of willingness to consume a maximum of two standard drinks per week while enrolled in the study and/or not willing to avoid alcohol consumption for 48 hour prior to test visits

Arms & Interventions

Healthy Diet + Cottonseed Oil (CSOD)

Experimental

Healthy dietary pattern containing 40g/day/2000 kcal of cottonseed oil (CSO)

Intervention: Healthy Dietary Pattern with Cottonseed Oil (Other)

Healthy Diet + Fatty Acid-Matched Plant Oils (FAMD)

Active Comparator

Healthy dietary pattern containing 40g/day/2000 kcal of a blend of plant oils comprising a fatty acid profile that matches the CSOD but devoid of CSO

Intervention: Healthy Dietary Pattern with Fatty Acid-Matched Plant Oils (Other)

Healthy Diet + PUFA:SFA Ratio-Matched Plant Oil (P:S-MD)

Active Comparator

Healthy dietary pattern containing 40g/day/2000 kcal of plant oil that is lower in polyunsaturated fatty acids (PUFA) and saturated fatty acids (SFA) than the CSOD, but with a matched PUFA:SFA ratio and devoid of CSO.

Intervention: Healthy Dietary Pattern with PUFA:SFA Ratio-Matched Plant Oil (Other)

Outcomes

Primary Outcomes

LDL-cholesterol concentration

Time Frame: 4 weeks

Assessed from fasting blood draw expressed in mg/dL. LDL-cholesterol will be measured directly via enzymatic assay. The mean of the LDL-cholesterol values from day 1 and day 2 testing will be used for analysis.

Secondary Outcomes

  • HDL-cholesterol concentration(4 weeks)
  • Particle Size and Number of LDL, HDL, VLDL and Chylomicrons(4 weeks)
  • Brachial Systolic and Diastolic Blood Pressure(4 weeks)
  • Fasting Serum Insulin concentration(4 weeks)
  • Fasting Plasma Glucose concentration(4 weeks)
  • Triglycerides concentration(4 weeks)
  • Fasting Serum Fructosamine concentration(4 weeks)
  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)(4 weeks)
  • Dihydrosterculic acid(4 weeks)
  • Total Cholesterol concentration(4 weeks)
  • Central Systolic and Diastolic Blood Pressure(4 weeks)
  • Carotid-Femoral Pulse Wave Velocity(4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kristina Petersen PhD, APD, FAHA

Associate Professor

Penn State University

Study Sites (1)

Loading locations...

Similar Trials